Your browser doesn't support javascript.
loading
A randomised multicentre phase II study with cisplatin/docetaxel vs oxaliplatin/docetaxel as first-line therapy in patients with advanced or metastatic non-small cell lung cancer.
Atmaca, A; Al-Batran, S-E; Werner, D; Pauligk, C; Güner, T; Koepke, A; Bernhard, H; Wenzel, T; Banat, A-G; Brueck, P; Caca, K; Prasnikar, N; Kullmann, F; Günther Derigs, H; Koenigsmann, M; Dingeldein, G; Neuhaus, T; Jäger, E.
Affiliation
  • Atmaca A; Department of Hematology and Oncology, Institute of Clinical Research (IKF) at Krankenhaus Nordwest, UCT-University Cancer Center, 60488 Frankfurt am Main, Germany. atmaca.akin@khnw.de
Br J Cancer ; 108(2): 265-70, 2013 Feb 05.
Article in En | MEDLINE | ID: mdl-23329236
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Organoplatinum Compounds / Antineoplastic Combined Chemotherapy Protocols / Cisplatin / Carcinoma, Non-Small-Cell Lung / Taxoids / Lung Neoplasms Type of study: Clinical_trials Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Br J Cancer Year: 2013 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Organoplatinum Compounds / Antineoplastic Combined Chemotherapy Protocols / Cisplatin / Carcinoma, Non-Small-Cell Lung / Taxoids / Lung Neoplasms Type of study: Clinical_trials Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Br J Cancer Year: 2013 Document type: Article